Development of a transformation model to derive general population-based utility: Mapping the pruritus-visual analog scale (VAS) to the EQ-5D utility

被引:10
|
作者
Park, Sun-Young [1 ]
Park, Eun-Ja [2 ]
Suh, Hae Sun [3 ]
Ha, Dongmun [1 ]
Lee, Eui-Kyung [1 ]
机构
[1] Sungkyunkwan Univ, Sch Pharm, 2066 Seobu Ro, Suwon 440746, Gyeonggi Do, South Korea
[2] Korea Inst Hlth & Social Affairs, Dept Res, Ctr Drug Policy, Seoul, South Korea
[3] Pusan Natl Univ, Coll Pharm, Busan, South Korea
关键词
economic evaluation; EQ-5D; mapping; pruritus; pruritus-VAS; utility; QUALITY-OF-LIFE; HEALTH STATE UTILITIES; CLINICAL CHARACTERISTICS; PREFERENCE VALUES; SF-12; VALIDITY; OUTCOMES; SCORES; IMPACT; INDEX;
D O I
10.1111/jep.12711
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Rationale, aims, and objectives Although nonpreference-based disease-specific measures are widely used in clinical studies, they cannot generate utilities for economic evaluation. A solution to this problem is to estimate utilities from disease-specific instruments using the mapping function. This study aimed to develop a transformation model for mapping the pruritus-visual analog scale (VAS) to the EuroQol 5-Dimension 3-Level (EQ-5D-3L) utility index in pruritus. Methods A cross-sectional survey was conducted with a sample (n = 268) drawn from the general population of South Korea. Data were randomly divided into 2 groups, one for estimating and the other for validating mapping models. To select the best model, we developed and compared 3 separate models using demographic information and the pruritus-VAS as independent variables. The predictive performance was assessed using the mean absolute deviation and root mean square error in a separate dataset. Results Among the 3 models, model 2 using age, age squared, sex, and the pruritus-VAS as independent variables had the best performance based on the goodness of fit and model simplicity, with a log likelihood of 187.13. The 3 models had similar precision errors based on mean absolute deviation and root mean square error in the validation dataset. No statistically significant difference was observed between the mean observed and predicted values in all models. Conclusions In conclusion, model 2 was chosen as the preferred mapping model. Outcomes measured as the pruritus-VAS can be transformed into the EQ-5D-3L utility index using this mapping model, which makes an economic evaluation possible when only pruritus-VAS data are available.
引用
收藏
页码:755 / 761
页数:7
相关论文
共 20 条
  • [1] The utility score of epilepsy with partial seizure measured by TTO, VAS, and EQ-5D in the general Korean population
    Kang, Hee-Jin
    Kang, Eunjeong
    Jo, Min-Woo
    Park, Eun-Ja
    Yoon, Seonyoung
    Lee, Eui-Kyung
    EPILEPSY RESEARCH, 2014, 108 (05) : 963 - 971
  • [2] Deriving a mapping algorithm for converting SF-36 scores to EQ-5D utility score in a Korean population
    Kim, Seon-Ha
    Kim, Seon-Ok
    Lee, Sang-il
    Jo, Min-Woo
    HEALTH AND QUALITY OF LIFE OUTCOMES, 2014, 12
  • [3] Population-Based Preference Weights for the EQ-5D Health States Using the Visual Analogue Scale (VAS) in Iran
    Goudarzi, Reza
    Zeraati, Hojjat
    Sari, Ali Akbari
    Rashidian, Arash
    Mohammad, Kazem
    IRANIAN RED CRESCENT MEDICAL JOURNAL, 2016, 18 (02)
  • [4] General Population Reference Values for the French Version of the EuroQol EQ-5D Health Utility Instrument
    Perneger, Thomas V.
    Combescure, Christophe
    Courvoisier, Delphine S.
    VALUE IN HEALTH, 2010, 13 (05) : 631 - 635
  • [5] Mapping health assessment questionnaire disability index (HAQ-DI) score, pain visual analog scale (VAS), and disease activity score in 28 joints (DAS28) onto the EuroQol-5D (EQ-5D) utility score with the KORean Observational study Network for Arthritis (KORONA) registry data
    Kim, Hye-Lin
    Kim, Dam
    Jang, Eun Jin
    Lee, Min-Young
    Song, Hyun Jin
    Park, Sun-Young
    Cho, Soo-Kyung
    Sung, Yoon-Kyoung
    Choi, Chan-Bum
    Won, Soyoung
    Bang, So-Young
    Cha, Hoon-Suk
    Choe, Jung-Yoon
    Chung, Won Tae
    Hong, Seung-Jae
    Jun, Jae-Bum
    Kim, Jinseok
    Kim, Seong-Kyu
    Kim, Tae-Hwan
    Kim, Tae-Jong
    Koh, Eunmi
    Lee, Hwajeong
    Lee, Hye-Soon
    Lee, Jisoo
    Lee, Shin-Seok
    Lee, Sung Won
    Park, Sung-Hoon
    Shim, Seung-Cheol
    Yoo, Dae-Hyun
    Yoon, Bo Young
    Bae, Sang-Cheol
    Lee, Eui-Kyung
    RHEUMATOLOGY INTERNATIONAL, 2016, 36 (04) : 505 - 513
  • [6] Mapping the English and Chinese Versions of the Functional Assessment of Cancer Therapy-General to the EQ-5D Utility Index
    Cheung, Yin-Bun
    Thumboo, Julian
    Gao, Fei
    Ng, Gim-Yew
    Pang, Grace
    Koo, Wen-Hsin
    Sethi, Vijay-Kumar
    Wee, Joseph
    Goh, Cynthia
    VALUE IN HEALTH, 2009, 12 (02) : 371 - 376
  • [7] Deriving a mapping algorithm for converting SF-36 scores to EQ-5D utility score in a Korean population
    Seon-Ha Kim
    Seon-Ok Kim
    Sang-il Lee
    Min-Woo Jo
    Health and Quality of Life Outcomes, 12
  • [8] Mapping the 25-item National Eye Institute Visual Functioning Questionnaire (NEI VFQ-25) to EQ-5D Utility Scores
    Kay, Stephen
    Ferreira, Alberto
    OPHTHALMIC EPIDEMIOLOGY, 2014, 21 (02) : 66 - 78
  • [9] Mapping the schizophrenia quality of life scale to EQ-5D, HUI3 and SF-6D utility scores in patients with schizophrenia
    Seow, Lee Seng Esmond
    Lau, Jue Hua
    Abdin, Edimansyah
    Verma, Swapna K.
    Tan, Kelvin Bryan
    Subramaniam, Mythily
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2023, 23 (07) : 813 - 821
  • [10] Using EQ-5D to derive general population-based utilities for the quality of life assessment of Growth Hormone Deficiency in Adults (QoL-AGHDA)
    Koltowska-Haggstrom, Maria
    Jonsson, Bjorn
    Isacson, Dag
    Bingefors, Kerstin
    VALUE IN HEALTH, 2007, 10 (01) : 73 - 81